Wan-Yu Tseng
Overview
Explore the profile of Wan-Yu Tseng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chase D, Iadeluca L, Lim J, Tseng W, Bulsara P, Patton G
Gynecol Oncol Rep
. 2024 Jul;
54:101440.
PMID: 39040942
Objective: Previous studies have shown that first-line (1L) maintenance therapy (MT) with poly(ADP-ribose) polymerase inhibitors and/or bevacizumab improves outcomes among patients with advanced ovarian cancer (OC); however, these treatments are...
2.
Goldschmidt J, Tseng W, Wang Y, Espirito J, Vasudevan A, Silver M, et al.
Drugs Real World Outcomes
. 2024 Jun;
11(3):425-439.
PMID: 38896198
Background: For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of therapy. Initial treatment with platinum chemotherapy and/or an immune checkpoint...
3.
Chase D, Annavarapu S, Tseng W, Shi J, Szamreta E, Monberg M
Gynecol Oncol
. 2023 Dec;
180:79-85.
PMID: 38056115
Objectives: The objective of this study was to describe healthcare resource use (HCRU) in addition to treatment patterns and discontinuations, in patients with ovarian cancer (OC) initiating PARP inhibitor (PARPi)...
4.
Lee M, Chiang C, Tseng W, Ho C
J Dent Sci
. 2023 Oct;
18(4):1952-1955.
PMID: 37799893
No abstract available.
5.
Black C, Ramakrishnan K, Nadler E, Tseng W, Wentworth C, Murphy J, et al.
Front Oncol
. 2023 Sep;
13:1155893.
PMID: 37664029
Introduction: There is a need to understand the current treatment landscape for LA HNSCC in the real-world setting. Methods: This retrospective study assessed real-world outcomes and treatment patterns of 1,158...
6.
Tseng W, Tsai Y, Lai E, Wang C, Lin T, Lin L, et al.
J Dent Sci
. 2023 Apr;
18(2):775-780.
PMID: 37021234
Background/purpose: The simulated pre-clinical operation skill test (PCOST) is part of the objective structured clinical examination (OSCE) and designed for clinical practice using manikins, physical typodonts, and instruments in the...
7.
Tseng W, Lai E, Wang T, Wang C, Lin T, Lin L, et al.
J Dent Sci
. 2023 Apr;
18(2):754-760.
PMID: 37021229
Background/purpose: The objective structured clinical examination (OSCE) is a test designed to test technical, clinical, and practical competency in medicine teaching. This study tried to evaluate the influencing factors of...
8.
Hwang G, Chang P, Tseng W, Chou C, Wu C, Tu Y
Comput Inform Nurs
. 2022 Dec;
40(12):814-824.
PMID: 36516032
The present study referred to the technology-based learning model to conduct a systematic review of the dimensions of nursing activities, research samples, research methods, roles of artificial intelligence, applied artificial...
9.
Hsu S, Liao H, Chen R, Chiu S, Tsai F, Lee M, et al.
J Formos Med Assoc
. 2022 Nov;
122(3):230-238.
PMID: 36372624
Background/purpose: To investigate the surface characteristics of titanium (Ti) implant materials, which were coated with different thicknesses of nanoscale tin oxide (SnO) using the atomic layer deposition technique, and evaluated...
10.
Pokras S, Tseng W, Espirito J, Beeks A, Culver K, Nadler E
Future Oncol
. 2022 Aug;
18(32):3637-3650.
PMID: 36018238
To examine and understand patient characteristics, treatment patterns and outcomes for patients with metastatic synovial sarcoma (mSS) treated in a US community setting. Retrospective observational study in adults with mSS...